FFA
CLOV icon

Frazier Financial Advisors’s Clover Health Investments CLOV Stock Holding History

Frazier Financial Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-128
Closed -$158 – 892
2024
Q2 		$158 Hold
128
– – ﹤0.01% 926
2024
Q1 		$102 Hold
128
– – ﹤0.01% 891
2023
Q4 		$122 Buy
+128
New +$126 ﹤0.01% 831

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Frazier Financial Advisors's CLOV Position: Q3 2024 in Review

Frazier Financial Advisors sold out of Clover Health Investments (CLOV) in Q3 2024, closing a stake of 128 shares — an estimated $158 sold.

Frazier Financial Advisors first reported a position in CLOV in Q4 2023 and held it in 3 quarters. The position peaked at $158 in Q2 2024. 159 funds tracked by Wall St. Rank hold CLOV as of Q3 2024.

  • Frazier Financial Advisors reported no remaining Clover Health Investments position as of Q3 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 128 Clover Health Investments shares in Q3 2024, an estimated $158.
  • Frazier Financial Advisors first reported a position in Clover Health Investments in Q4 2023 and held it in 3 quarters.
  • Frazier Financial Advisors's Clover Health Investments position peaked at $158 in Q2 2024.
  • 159 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2024.

Based on Frazier Financial Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.